Mycapssa
NDC 69880-120, Octreotide, capsule, delayed release, from Amryt Pharmaceuticals Designated Activity Company.
- Product NDC
- 69880-120
- Status
- Listed
- Labeler
- Amryt Pharmaceuticals Designated Activity Company
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208232
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69880-120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTREOTIDE20 mg/1
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69880-120-28 | 69880012028 | 4 BLISTER PACK in 1 DOSE PACK (69880-120-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/62a5e1eb-b48e-4ea6-8781-f75e490b17e4
Use it
Look up 69880-120 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69880-120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69880-120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.